These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval. O'Reilly JT. Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397 [No Abstract] [Full Text] [Related]
24. Patient package inserts: the proper prescription? Rowe HM. Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988 [No Abstract] [Full Text] [Related]
33. FDA, off-label use, and informed consent: debunking myths and misconceptions. Beck JM, Azari ED. Food Drug Law J; 1998; 53(1):71-104. PubMed ID: 11795338 [No Abstract] [Full Text] [Related]
34. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly. Vladeck DC. Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967 [No Abstract] [Full Text] [Related]
35. Tricky FDA debate: should a risky drug be approved again? Mathews AW, Westphal SP. Wall St J (East Ed); 2006 Feb 24; ():B1, B4. PubMed ID: 16528879 [No Abstract] [Full Text] [Related]